Research map: The Impact of Chronic Hepatitis D Virus Infection on Health‐Related Quality of Life and Fatigue: A Real‐World International Study

Back to the article

Papers in this map

  1. The Fatigue Severity Scale · Lauren Krupp · 1989 · 6139 citations · Cited by this paper
  2. A New Model for Hepatitis C Elimination: CDC‐Dispatching Follow‐Up Coordinators Stationed in Hospitals · 2026 · Related
  3. EQ-SD: a measure of health status from the EuroQol Group · Rosalind Rabin · 2001 · 5750 citations · Cited by this paper
  4. Setting the Record Straight: Utility and Outcomes in Patients With HCV Related HCC · 2026 · Related
  5. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance · Norah A. Terrault · 2018 · 4395 citations · Cited by this paper
  6. Effectiveness, Safety and Patient‐Reported Outcomes of Bulevirtide Therapy in Chronic Hepatitis Delta: Real‐World Evidence From a Prospective Observational Study · 2026 · Related
  7. When to use the B onferroni correction · Richard A. Armstrong · 2014 · 3100 citations · Cited by this paper
  8. Enhancing Chronic Hepatitis B and D Management Through a Tailored Mobile Health Application: Real‐World Outcomes From the Adaptation of the NORA App · 2026 · Related
  9. Validation of two global impression questionnaires for incontinence · Ilker Yalcin · 2003 · 898 citations · Cited by this paper
  10. Genotypes of Hepatitis B and D Viruses Among Patients With Hepatitis D in the United States · 2026 · Related
  11. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis · Alexander J. Stockdale · 2020 · 695 citations · Cited by this paper
  12. Differential Hepatitis B Surface Antigen Glycan Isomer Kinetics Between Tenofovir Alafenamide and Entecavir: Hepatocellular Carcinoma Risk Stratification in Hepatitis B e Antigen‐Positive Patients · 2026 · Related
  13. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B · Giovanna Fattovich · 2000 · 514 citations · Cited by this paper
  14. Delivering Effective Hepatitis C Virus Treatment in an Embedded Primary Care Setting Within a Tertiary Care Hospital in Karachi, Pakistan · 2026 · Related
  15. Population Norms for the EQ-5D · Bas Janssen · 2013 · 258 citations · Cited by this paper
  16. Telemedicine for Low‐Barrier Hepatitis C Care in Rural Patients With Substance Use Disorders: Lessons From Taiwan · 2026 · Related
  17. A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D · Heiner H. Wedemeyer · 2023 · 242 citations · Cited by this paper
  18. Real‐World Impact of a Simplified ‘Test and Treat’ Strategy for In‐Hospital HCV Micro‐Elimination · 2026 · Related
  19. Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances · Chen Shen · 2023 · 158 citations · Cited by this paper
  20. Health related quality of life in people with advanced chronic liver disease · James G. Orr · 2014 · 149 citations · Cited by this paper
  21. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories · Devin Razavi‐Shearer · 2023 · 108 citations · Cited by this paper
  22. Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index · Amy A. Dan · 2008 · 72 citations · Cited by this paper
  23. Health-related quality of life in patients with compensated and decompensated liver cirrhosis · Christian Labenz · 2019 · 71 citations · Cited by this paper
  24. Treating hepatitis D with bulevirtide – Real-world experience from 114 patients · Christopher Dietz-Fricke · 2023 · 67 citations · Cited by this paper
  25. Health-related quality of life in patients with different stages of liver disease induced by hepatitis C · Einar Björnsson · 2009 · 66 citations · Cited by this paper
  26. Hepatitis delta virus testing, epidemiology and management: A multicentre cross-sectional study of patients in London · Kate El Bouzidi · 2015 · 50 citations · Cited by this paper
  27. A Systematic Review and Meta-Analysis of Health Utilities in Patients With Chronic Hepatitis C · Yasmin A. Saeed · 2019 · 45 citations · Cited by this paper
  28. Abstracts · Mads Egerod Israelsen · 2022 · 41 citations · Cited by this paper
  29. Interplay between Hepatitis D Virus and the Interferon Response · Zhenfeng Zhang · 2020 · 33 citations · Cited by this paper
  30. The Liver Meeting: Boston, Massachusetts Nov 10-14, 2023 · Massimiliano Cadamuro · 2023 · 32 citations · Cited by this paper
  31. Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B · Marı́a Buti · 2021 · 26 citations · Cited by this paper
  32. Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide · Marı́a Buti · 2024 · 23 citations · Cited by this paper
  33. The elimination of hepatitis D as a public health problem: Needs and challenges · Thomas Vanwolleghem · 2023 · 19 citations · Cited by this paper
  34. New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection · Lisa Sandmann · 2021 · 18 citations · Cited by this paper
  35. Estimating the prevalence of hepatitis delta virus infection among adults in the United States: A meta‐analysis · Robert J. Wong · 2024 · 17 citations · Cited by this paper
  36. Patient health utility, work productivity, and lifestyle impairment in chronic hepatitis C patients in France · Jennifer C. Samp · 2014 · 15 citations · Cited by this paper
  37. Severe impairment of patient‐reported outcomes in patients with chronic hepatitis C virus infection seen in real‐world practices across the world: Data from the global liver registry · Zobair M. Younossi · 2022 · 13 citations · Cited by this paper
  38. Improvement of health-related quality of life and psychological well-being after HCV eradication with direct-acting antiviral agents. Real life setting data of an Italian cohort valued by Hepatitis Quality of Life Questionnaire (HQLQv2) · Gaetano Bertino · 2020 · 9 citations · Cited by this paper
  39. Epidemiology Pattern, Prevalent Genotype Distribution, Fighting Stigma and Control Options for Hepatitis D in Bulgaria and Other European Countries · Denitsa Tsaneva · 2023 · 9 citations · Cited by this paper

Source: OpenAlex (CC0)